{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:46:55Z","timestamp":1771307215181,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.metabol.2006.09.006","type":"journal-article","created":{"date-parts":[[2006,12,9]],"date-time":"2006-12-09T07:14:56Z","timestamp":1165648496000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"56","author":[{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystallenia","family":"Alexandraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Aessopos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Paterakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2006.09.006_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1043-2760(96)00125-7","article-title":"New perspectives in polycystic ovary syndrome","volume":"7","author":"Diamanti-Kandarakis","year":"1996","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.09.006_bib2","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.09.006_bib3","first-page":"795","article-title":"The prevalence of 4G5G polymorphism of plasminogen activator inhibitor\u20131 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels","volume":"150","author":"Diamanti-Kandarakis","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2006.09.006_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2006.09.006_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2006.09.006_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2006.09.006_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.metabol.2005.10.011","article-title":"Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome","volume":"55","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2006.09.006_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2796.2002.00932.x","article-title":"Diabetes and advanced glycation endproducts","volume":"251","author":"Vlassara","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2006.09.006_bib9","first-page":"138","article-title":"Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging","volume":"70","author":"Vlassara","year":"1994","journal-title":"Lab Invest"},{"key":"10.1016\/j.metabol.2006.09.006_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.1995.322","article-title":"Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy","volume":"48","author":"Makino","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2006.09.006_bib11","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1172\/JCI116482","article-title":"Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus","volume":"91","author":"McCance","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2006.09.006_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus, I. The AGE concept","volume":"37","author":"Bierhaus","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2006.09.006_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/12.2.255","article-title":"Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure","volume":"12","author":"Miyata","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2006.09.006_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0009-8981(00)00327-2","article-title":"Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation","volume":"301","author":"Rahbar","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2006.09.006_bib15","doi-asserted-by":"crossref","first-page":"6S95","DOI":"10.1016\/S1262-3636(03)72793-1","article-title":"Metformin inhibition of glycation processes","volume":"29","author":"Beisswenger","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2006.09.006_bib16","first-page":"647","article-title":"Metformin therapy in PCO reduces hyperinsulinemia, insulin resistance, hyperandrogenism","volume":"43","author":"Velazguez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2006.09.006_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.09.006_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2006.09.006_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","article-title":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes","volume":"48","author":"Beisswenger","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2006.09.006_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2006.09.006_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0021-9150(98)00149-X","article-title":"Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions","volume":"141","author":"Sakata","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2006.09.006_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2006.09.006_bib23","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.09.006_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2006.09.006_bib25","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0006-2952(99)00263-4","article-title":"Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation","volume":"58","author":"Ruggiero-Lopez","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2006.09.006_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cccn.2005.02.012","article-title":"Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal","volume":"358","author":"Kiho","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2006.09.006_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(99)00342-8","article-title":"Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats","volume":"376","author":"Tanaka","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2006.09.006_bib28","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1074\/jbc.273.15.8630","article-title":"Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products","volume":"273","author":"Sano","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2006.09.006_bib29","first-page":"E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2006.09.006_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2006.09.006_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/meta.2002.28970","article-title":"Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans","volume":"51","author":"Abassi","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2006.09.006_bib32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506003404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506003404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:10:28Z","timestamp":1758424228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049506003404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0026049506003404"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2006.09.006","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2006.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}